These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 24157687)
1. Antipsychotic discontinuation in patients with dementia: a systematic review and meta-analysis of published randomized controlled studies. Pan YJ; Wu CS; Gau SS; Chan HY; Banerjee S Dement Geriatr Cogn Disord; 2014; 37(3-4):125-40. PubMed ID: 24157687 [TBL] [Abstract][Full Text] [Related]
2. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
3. Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65 Years and Older With Dementia. Van Leeuwen E; Petrovic M; van Driel ML; De Sutter AI; Stichele RV; Declercq T; Christiaens T J Am Med Dir Assoc; 2018 Nov; 19(11):1009-1014. PubMed ID: 30100234 [TBL] [Abstract][Full Text] [Related]
4. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials. Matsunaga S; Kishi T; Iwata N J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482 [TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. Lee PE; Gill SS; Freedman M; Bronskill SE; Hillmer MP; Rochon PA BMJ; 2004 Jul; 329(7457):75. PubMed ID: 15194601 [TBL] [Abstract][Full Text] [Related]
6. The effects of abrupt antipsychotic discontinuation in cognitively impaired older persons: a pilot study. Azermai M; Petrovic M; Engelborghs S; Elseviers MM; Van der Mussele S; Debruyne H; Van Bortel L; Vander Stichele RH Aging Ment Health; 2013; 17(1):125-32. PubMed ID: 22928861 [TBL] [Abstract][Full Text] [Related]
7. Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): a meta-analysis of randomised placebo-controlled trials. Cheung G; Stapelberg J N Z Med J; 2011 Jun; 124(1336):39-50. PubMed ID: 21946743 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials. Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323 [TBL] [Abstract][Full Text] [Related]
9. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Schneider LS; Dagerman KS; Insel P JAMA; 2005 Oct; 294(15):1934-43. PubMed ID: 16234500 [TBL] [Abstract][Full Text] [Related]
10. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials. Kishi T; Matsuda Y; Iwata N; Correll CU J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105 [TBL] [Abstract][Full Text] [Related]
11. Do antipsychotics lead to cognitive impairment in dementia? A meta-analysis of randomised placebo-controlled trials. Wolf A; Leucht S; Pajonk FG Eur Arch Psychiatry Clin Neurosci; 2017 Apr; 267(3):187-198. PubMed ID: 27530185 [TBL] [Abstract][Full Text] [Related]
12. Anticonvulsants for behavioral and psychological symptoms in dementia: protocol for a systematic review. Benjamin S; Williams JW; Cotton C; Tung J; An H; Sanger S; Ho JM Syst Rev; 2019 May; 8(1):118. PubMed ID: 31103045 [TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. van Reekum R; Clarke D; Conn D; Herrmann N; Eryavec G; Cohen T; Ostrander L Int Psychogeriatr; 2002 Jun; 14(2):197-210. PubMed ID: 12243210 [TBL] [Abstract][Full Text] [Related]
14. Mortality in elderly dementia patients treated with risperidone. Haupt M; Cruz-Jentoft A; Jeste D J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812 [TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598 [TBL] [Abstract][Full Text] [Related]
16. Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: an update review. Yeh YC; Ouyang WC Kaohsiung J Med Sci; 2012 Apr; 28(4):185-93. PubMed ID: 22453066 [TBL] [Abstract][Full Text] [Related]
17. Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events. van Iersel MB; Zuidema SU; Koopmans RT; Verhey FR; Olde Rikkert MG Drugs Aging; 2005; 22(10):845-58. PubMed ID: 16245958 [TBL] [Abstract][Full Text] [Related]
18. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study. Ruths S; Straand J; Nygaard HA; Bjorvatn B; Pallesen S J Am Geriatr Soc; 2004 Oct; 52(10):1737-43. PubMed ID: 15450054 [TBL] [Abstract][Full Text] [Related]
19. Effects of music therapy on behavioral and psychological symptoms of dementia: a systematic review and meta-analysis. Ueda T; Suzukamo Y; Sato M; Izumi S Ageing Res Rev; 2013 Mar; 12(2):628-41. PubMed ID: 23511664 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of atypical antipsychotics for behavioral symptoms of dementia among patients residing in long-term care. Sturm AS; Trinkley KE; Porter K; Nahata MC Int J Clin Pharm; 2018 Feb; 40(1):135-142. PubMed ID: 29189977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]